HSBC Holdings’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.57M Buy
91,279
+70,445
+338% +$6.63M ﹤0.01% 1020
2026
Q1
$1.84M Sell
20,834
-31,445
-60% -$3.23M ﹤0.01% 1570
2025
Q4
$4.97M Buy
+52,279
New +$5.27M ﹤0.01% 1213
2023
Q2
Sell
-1,824
Closed -$227K 2574
2023
Q1
$227K Buy
1,824
+36
+2% +$4.94K ﹤0.01% 2339
2022
Q4
$264K Sell
1,788
-448
-20% -$68.9K ﹤0.01% 2626
2022
Q3
$304K Sell
2,236
-29,634
-93% -$4.53M ﹤0.01% 2406
2022
Q2
$4.83M Buy
31,870
+25,985
+442% +$3.97M 0.01% 1210
2022
Q1
$1.01M Buy
5,885
+4,558
+343% +$766K ﹤0.01% 1941
2021
Q4
$344K Sell
1,327
-6,386
-83% -$1.75M ﹤0.01% 2690
2021
Q3
$2.13M Buy
7,713
+3,102
+67% +$986K ﹤0.01% 1503
2021
Q2
$1.03M Sell
4,611
-1,517
-25% -$286K ﹤0.01% 1755
2021
Q1
$661K Sell
6,128
-11,613
-65% -$1.23M ﹤0.01% 1817
2020
Q4
$1.46M Sell
17,741
-48,916
-73% -$4.8M ﹤0.01% 1476
2020
Q3
$4.6M Buy
+66,657
New +$4.78M 0.01% 986

Other funds holding BNTX

HSBC Holdings's BNTX Position: Q2 2026 in Review

HSBC Holdings increased its BioNTech (BNTX) stake by 338% in Q2 2026, buying an estimated $6.63M and bringing the position to 91,279 shares worth $8.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

HSBC Holdings first reported a position in BNTX in Q3 2020 and has held it in 14 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • HSBC Holdings held 91,279 shares of BioNTech worth $8.57M as of Q2 2026.
  • HSBC Holdings bought 70,445 BioNTech shares in Q2 2026, an estimated $6.63M.
  • BioNTech made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1020 holding.
  • HSBC Holdings first reported a position in BioNTech in Q3 2020 and has held it in 14 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.